This application will examine the in vivo actions of a newly described putative dopaminotrophic (DA) factor, glial cell-derived neurotrophic factor (GDNF) in rats. The proposal will test the hypotheses that GDNF is a specific trophic factor for developing, mature and aged midbrain DA neurons, that GDNF will support human as well as rat DA circuits, and that GDNF will counteract the deleterious effects of dopaminergic neurotoxins. It is proposed to examine actions of GDNF in grafts of fetal neuroblasts placed in oculo. Effects of neuron age will be determined by comparing GDNF activity in developing, mature and aged DA grafts. Specificity will be determined by comparing GDNF activity in DA-, NE- and 5HT-containing grafts. Target influences will be addressed by examining GDNF activity in DA double grafts with striatal, hippocampal or iris targets. Finally, GDNF activity will be evaluated in xenografts of fetal human DA neuroblasts in oculo. It is also proposed to examine actions of GDNF on dopaminergic pathways in intact rats and mice. GDNF will be administered intracranially in 3-, 18-, and 24-month old rats to study effects of CNS age. Interactions of GDNF with dopaminergic neurotoxins, such as 6OHDA (rats) and MPTP (mice) will be evaluated both with """"""""protection"""""""" and with facilitation of regeneration protocols. Target appropriateness will be evaluated in situ. Finally, GDNF will be studied in mature and immature syngeneic and allogeneic intracranial grafts and in immature human xenografts to gain further insight into the utility of this molecule to augment growth, differentiation, maintenance, and survival of DA neurons. Actions of GDNF will be evaluated using behavioral, histochemical and in vivo electrochemical techniques. Neurochemical and electrophysiological protocols will also be utilized.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Scientist Award (K05)
Project #
5K05MH000289-17
Application #
2239731
Study Section
Neuropharmacology and Neurochemistry Review Committee (NPNC)
Project Start
1980-01-01
Project End
1998-08-31
Budget Start
1996-03-15
Budget End
1998-08-31
Support Year
17
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Pharmacology
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Freedman, R; Stromberg, I; Nordstrom, A L et al. (1994) Neuronal development in embryonic brain tissue derived from schizophrenic women and grafted to animal hosts. Schizophr Res 13:259-70
Freedman, R; Stromberg, I; Seiger, A et al. (1992) Initial studies of embryonic transplants of human hippocampus and cerebral cortex derived from schizophrenic women. Biol Psychiatry 32:1148-63
Palmer, M R; Henschen, A; Trok, K et al. (1991) Functional innervation of spinal cord tissue by fetal neocortical grafts in oculo: an electrophysiological study. Exp Brain Res 87:96-107
Hoffer, B J; Olson, L; Palmer, M R (1987) Toxic effects of lead in the developing nervous system: in oculo experimental models. Environ Health Perspect 74:169-75
Lindvall, O; Backlund, E O; Farde, L et al. (1987) Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol 22:457-68
Olson, L; Backlund, E O; Gerhardt, G et al. (1987) Nigral and adrenal grafts in parkinsonism: recent basic and clinical studies. Adv Neurol 45:85-94
Stromberg, I; Johnson, S; Hoffer, B et al. (1985) Reinnervation of dopamine-denervated striatum by substantia nigra transplants: immunohistochemical and electrophysiological correlates. Neuroscience 14:981-90
Rose, G; Gerhardt, G; Stromberg, I et al. (1985) Monoamine release from dopamine-depleted rat caudate nucleus reinnervated by substantia nigra transplants: an in vivo electrochemical study. Brain Res 341:92-100